INTRODUCTION Patients with persistent methicillin-resistant Staphylococcus aureus (MRSA) infections, which are associated with high mortality rates, often require prolonged hospitalizations, intensive care services, extended use of costly alternative antimicrobial therapies, and increased treatment for disease-related complications (1–4). Addressing these challenges remains a critical concern in both clinical and public health settings.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Andrew
Contact Andrew, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack